Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$25.89 - $29.73 $1.87 Million - $2.14 Million
-72,144 Reduced 97.49%
1,859 $51,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $1.93 Million - $2.51 Million
74,003 New
74,003 $2.13 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $1.47 Million - $1.79 Million
33,530 Added 234.49%
47,829 $2.09 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $1.44 Million - $1.71 Million
-30,959 Reduced 68.41%
14,299 $750,000
Q4 2021

Feb 14, 2022

BUY
$41.32 - $61.25 $749,296 - $1.11 Million
18,134 Added 66.86%
45,258 $2.67 Million
Q3 2021

Nov 15, 2021

SELL
$39.25 - $50.42 $3.7 Million - $4.75 Million
-94,273 Reduced 77.66%
27,124 $1.17 Million
Q3 2020

Nov 16, 2020

BUY
$31.75 - $37.25 $683,450 - $801,843
21,526 Added 21.55%
121,397 $4.46 Million
Q2 2020

Aug 14, 2020

SELL
$30.12 - $36.54 $1.37 Million - $1.66 Million
-45,550 Reduced 31.32%
99,871 $3.27 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $3.1 Million - $4.44 Million
114,840 Added 375.53%
145,421 $4.75 Million
Q4 2019

Feb 14, 2020

SELL
$32.92 - $37.36 $134,972 - $153,176
-4,100 Reduced 11.82%
30,581 $1.2 Million
Q3 2019

Nov 14, 2019

BUY
$32.49 - $42.13 $330,358 - $428,377
10,168 Added 41.48%
34,681 $1.25 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $634,613 - $712,524
17,161 Added 233.42%
24,513 $1.06 Million
Q1 2019

May 15, 2019

BUY
$37.5 - $41.2 $275,700 - $302,902
7,352 New
7,352 $312,000
Q4 2018

Feb 14, 2019

SELL
$38.47 - $43.86 $275,291 - $313,862
-7,156 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $80,694 - $97,877
2,341 Added 48.62%
7,156 $315,000
Q2 2018

Aug 14, 2018

BUY
$32.98 - $35.16 $156,622 - $166,974
4,749 Added 7195.45%
4,815 $175,000
Q1 2018

May 15, 2018

BUY
$31.91 - $37.02 $2,106 - $2,443
66 New
66 $2,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.